These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


265 related items for PubMed ID: 30882198

  • 1. Direct Inhibition of MmpL3 by Novel Antitubercular Compounds.
    Li W, Stevens CM, Pandya AN, Darzynkiewicz Z, Bhattarai P, Tong W, Gonzalez-Juarrero M, North EJ, Zgurskaya HI, Jackson M.
    ACS Infect Dis; 2019 Jun 14; 5(6):1001-1012. PubMed ID: 30882198
    [Abstract] [Full Text] [Related]

  • 2. A piperidinol-containing molecule is active against Mycobacterium tuberculosis by inhibiting the mycolic acid flippase activity of MmpL3.
    Dupont C, Chen Y, Xu Z, Roquet-Banères F, Blaise M, Witt AK, Dubar F, Biot C, Guérardel Y, Maurer FP, Chng SS, Kremer L.
    J Biol Chem; 2019 Nov 15; 294(46):17512-17523. PubMed ID: 31562241
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3.
    Li W, Obregón-Henao A, Wallach JB, North EJ, Lee RE, Gonzalez-Juarrero M, Schnappinger D, Jackson M.
    Antimicrob Agents Chemother; 2016 Sep 15; 60(9):5198-207. PubMed ID: 27297488
    [Abstract] [Full Text] [Related]

  • 6. HC2091 Kills Mycobacterium tuberculosis by Targeting the MmpL3 Mycolic Acid Transporter.
    Zheng H, Williams JT, Coulson GB, Haiderer ER, Abramovitch RB.
    Antimicrob Agents Chemother; 2018 Jul 15; 62(7):. PubMed ID: 29661875
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MmpL3 inhibitors as antituberculosis drugs.
    Shao M, McNeil M, Cook GM, Lu X.
    Eur J Med Chem; 2020 Aug 15; 200():112390. PubMed ID: 32447196
    [Abstract] [Full Text] [Related]

  • 9. Mycobacterial Membrane Protein Large 3 (MmpL3) Inhibitors: A Promising Approach to Combat Tuberculosis.
    Umare MD, Khedekar PB, Chikhale RV.
    ChemMedChem; 2021 Oct 15; 16(20):3136-3148. PubMed ID: 34288519
    [Abstract] [Full Text] [Related]

  • 10. MmpL3 Inhibitors: Diverse Chemical Scaffolds Inhibit the Same Target.
    Poce G, Consalvi S, Biava M.
    Mini Rev Med Chem; 2016 Oct 15; 16(16):1274-1283. PubMed ID: 26776226
    [Abstract] [Full Text] [Related]

  • 11. Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds In Vitro.
    Li W, Sanchez-Hidalgo A, Jones V, de Moura VC, North EJ, Jackson M.
    Antimicrob Agents Chemother; 2017 Apr 15; 61(4):. PubMed ID: 28115355
    [Abstract] [Full Text] [Related]

  • 12. Multiple Mutations in Mycobacterium tuberculosis MmpL3 Increase Resistance to MmpL3 Inhibitors.
    McNeil MB, O'Malley T, Dennison D, Shelton CD, Sunde B, Parish T.
    mSphere; 2020 Oct 14; 5(5):. PubMed ID: 33055263
    [Abstract] [Full Text] [Related]

  • 13. Structure-Function Profile of MmpL3, the Essential Mycolic Acid Transporter from Mycobacterium tuberculosis.
    Belardinelli JM, Yazidi A, Yang L, Fabre L, Li W, Jacques B, Angala SK, Rouiller I, Zgurskaya HI, Sygusch J, Jackson M.
    ACS Infect Dis; 2016 Oct 14; 2(10):702-713. PubMed ID: 27737557
    [Abstract] [Full Text] [Related]

  • 14. Two-Way Regulation of MmpL3 Expression Identifies and Validates Inhibitors of MmpL3 Function in Mycobacterium tuberculosis.
    Grover S, Engelhart CA, Pérez-Herrán E, Li W, Abrahams KA, Papavinasasundaram K, Bean JM, Sassetti CM, Mendoza-Losana A, Besra GS, Jackson M, Schnappinger D.
    ACS Infect Dis; 2021 Jan 08; 7(1):141-152. PubMed ID: 33319550
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis.
    Tahlan K, Wilson R, Kastrinsky DB, Arora K, Nair V, Fischer E, Barnes SW, Walker JR, Alland D, Barry CE, Boshoff HI.
    Antimicrob Agents Chemother; 2012 Apr 08; 56(4):1797-809. PubMed ID: 22252828
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.